Praxair, Inc. (NYSE:PX) and Apria Healthcare, Inc., have entered into a definitive agreement by which Praxair will sell its U.S. homecare business to Apria. Terms of the agreement were not disclosed. The transaction is expected to close during the first quarter 2011, subject to satisfaction of customary terms and conditions. A part of the company's broader North American healthcare business, Praxair's U.S. homecare business operates from 85 branch locations, providing home respiratory services and durable medical equipment to clients in their homes across 27 states and employs approximately 1,100 people.
Given Apria's broader and deeper capabilities in the U.S. homecare market, we believe Praxair's U.S. customers will be well served by this acquisition, said Scott Telesz, senior vice president of Praxair.
Praxair will continue to supply the homecare market in other countries, and also will continue to expand its very successful institutional healthcare business worldwide.
Praxair, Inc. is the largest industrial gases company in North and South America, and one of the largest worldwide, with 2010 sales of $10 billion.
Power3 Medical Products, Inc. (OTCBB:PWRM) recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few. In addition, Power3 Medical Products is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 Medical Products several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash.
Because current management believes these toxic debt instruments are responsible for Power3 Medical Products' depressed stock price and have distracted Power3 Medical Products from its mission, Power3 Medical Products plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 Medical Products will continue to rigorously defend its position. Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy.
Power3 Medical Products plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3 Medical Products, with Power3 Medical Products remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011. Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical Products applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
Through these processes, Power3 Medical Products has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which Power3 Medical Products has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which Power3 Medical Products is currently engaged in Phase II clinical trials.
Unity Management Group, Inc. (PINK:UYMG) is a Health Resource Company specializing in Physician and Hospital Practice Management, Medical Discount Plans, Business Services, Billing Software and Technologies, along with Pharmacy Instrumentation, and Calibration. Unity Management Group/MCC is proud to announce that orders are coming in for their new patented device known as Parcus Pro, that have exceeded all expectations. There are already 5 orders pending, totaling $265,000.00. Projects for Instrumentation and calibration of existing equipment, and maintenance contracts have also increased for the first quarter of 2011, compared to 2010.
Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians' practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.
Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).